Delivery Order SPE2DB22D9353-SPE2DB25FX2GE
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,561.15 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, is for the supply of Xolair 300 mg/2 ml auto-injector syringes to support Department of Defense healthcare operations. This award carries no set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,273.38 by the Defense Logistics Agency on August 26, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract carries no set-aside designation and is scheduled for completion by September 17, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on September 11, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was applied to this procurement action. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $28.3K by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, with no set-aside designation applied. The award represents a discrete fulfillment under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,697.84 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector medications. The delivery order, which carries no set-aside designation, is scheduled for completion by May 15, 2025, with performance occurring at the company's Park Ridge facility. This award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,321.10 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, awarded without set-aside designation, carries a firm fixed-price structure with an ultimate completion date of September 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,277.01 by the Defense Logistics Agency (DLA) on June 18, 2025, with an ultimate completion date of July 11, 2025. The contract covers the supply of Xolair 75 mg/0.5 ml auto-injector units and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,848.88 by the Defense Logistics Agency (DLA) on September 3, 2025. The contract calls for the delivery of Xolair 150 mg/ml auto-injector medication, with an ultimate completion date of September 24, 2025. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The award utilizes a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of May 15, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $38,685 by the Defense Logistics Agency on September 25, 2025, for the supply of Xolair 150 mg/ml syringes. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 17, 2025. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2GEDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 29, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units valued at $34,043.20. This firm fixed-price delivery order, which carries an ultimate completion date of October 21, 2025, was issued by the Defense Logistics Agency (DLA) without set-aside designation. The contract represents a specific pharmaceutical product delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA's SPE2DB program, a $500 million vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities. As a long-established federal supplier registered in the System for Award Management (SAM.gov) since 2001, DMS Pharmaceutical Group has developed a robust portfolio of pharmaceutical contract awards with the DLA, demonstrating consistent capability in distributing branded and generic prescription medications, biologics, and medical consumables to military health facilities nationwide. The company's position as a woman-owned small business has enabled it to compete effectively in federal procurement while maintaining significant contracts across diverse pharmaceutical categories, from contraceptive devices to oncology treatments and specialty auto-injectors like Xolair, which is used to treat moderate-to-severe allergic asthma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 9/29/25 |